This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Haller, H. Articles by Menne, J. Search for Related Content PubMed PubMed Citation Articles by Haller, H. Articles by Menne, J. Social Bookmarking                         What's this?

Intrarenal renin-angiotensin system — important player of the local milieu

Department of Nephrology, Hannover Medical School, Hannover, Germany

Joon-Keun Park

Department of Nephrology, Hannover Medical School, Hannover, Germany

Carsten Lindschau

Department of Nephrology, Hannover Medical School, Hannover, Germany

Matthias Meyer

Department of Nephrology, Hannover Medical School, Hannover, Germany

Jan Menne

Department of Nephrology, Hannover Medical School, Hannover, Germany

References

• Lansang M., Price D., Laffel L. et al. Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. Kidney Int 2001;59:1432-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Navar L. The intrarenal renin-angiotensin system in hypertension. Kidney Int 2004;65:1522-32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Navar L., Harrison-Bernard L., Nishiyama A., Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002;39:316-22.[Abstract/Free Full Text]
• Kobori H., Nishiyama A., Abe Y., Navar L. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003;41:529-97.
• Kobori H., Prieto-Carrasquero M., Ozawa Y., Navar L. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 2004;43:1126-32.[Abstract/Free Full Text]
• Nishiyama A., Seth D., Navar L. Renal interstitial concentrations of angiotensins I and II in anesthestized rats. Hypertension 2002;39:129-34.[Abstract/Free Full Text]
• Navar LG, Imig JD, Zou L., Wang C-T. Intrarenal production of angiotensin II. Sem Nephrol 1997;17:412-22.production[Web of Science][Medline] [Order article via Infotrieve]
• Ingelfinger J., Zuo WM, Fon EA, Ellison KE, Dzau VJ In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. J Clin Invest 1990;85:417-23.[Web of Science][Medline] [Order article via Infotrieve]
• Kobori H., Harrison-Bernard LM, Navar LG Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Hypertension 2003;41(1): 42-9.[Abstract/Free Full Text]
• Liebau MC, Lang D., Bohm J. et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006;290(3):F710-F719.[Abstract/Free Full Text]
• Navar LG, Harrison-Bernard LM, Imig JD Compartmentalization of intrarenal angiotensin II. In: Ulfendahl HR, Aurell M, eds. Renin-Angiotensin. London: Portland Press;1998:193-208.
• Wilcox CS, Dzau VJ Effect of captopril on the release of the components of the renin-angiotensin system into plasma and lymph. J Am Soc Nephrol 1992;2:1241-50.[Abstract]
• Cowley AW Jr, Mori T., Mattson D., Zou A-P. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regulatory Integrative Comp Physiol 2003; 284(6):R1355-R1369.[Abstract/Free Full Text]
• Navar L., Inscho E., Majid S., Imig J., Harrison-Bernard L., Mitchell K. Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-536.[Abstract/Free Full Text]
• Paxton WG, Runge M., Horaist C., Cohen C., Alexander RW, Bernstein KE Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol-Renal Physiol 1993;264:F989-F995.[Abstract/Free Full Text]
• DiBona GF Dynamic analysis of patterns of renal sympathetic nerve activity: implications for renal function. Exp Physiol 2005;90(2):159-61.[Abstract/Free Full Text]
• Miyata N., Park F., Li XF, Cowley Jr AW Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol-Renal Physiol 1999;277:F437-F446.[Abstract/Free Full Text]
• Haller H., Lindschau C., Erdmann B., Quass P., Luft FC Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res 1996;79:765-72.[Abstract/Free Full Text]
• Anderson KM, Peach MJ Receptor binding and internalization of a unique biologically active angiotensin II-colloidal gold conjugate: Morphological analysis of angiotensin II processing in isolated vascular strips. J Vasc Res 1994;31:10-17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Re R. The nature of intracrine peptide hormone action. Hypertension 1999;34:534-8.[Abstract/Free Full Text]
• Chen R., Mukhin YV, Garnovskaya MN et al. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol-Renal Physiol 2000;279:F440-F44.[Abstract/Free Full Text]
• Loghman-Adham M., Soto CE, Inagami T., Cassis L. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol 2004;287(4):F775-F788.[Abstract/Free Full Text]
• Almeida WS, Maciel TT, Di Marco GS, Casarini DE, Campos AH, Schor N. Escherichia coli lipopolysaccharide inhibits renin activity in human mesangial cells. Kidney Int 2006;69(6):974-80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Graciano ML, de Cassia Cavaglieri R., Dellê H. et al. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 2004;15:1805-15.[Abstract/Free Full Text]
• Carey RM, Siragy HM The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 2003;14(6):274-81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hollenberg NK, Price DA, Fisher ND et al. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney Int 2003;63 (1):172-8.[Web of Science][Medline] [Order article via Infotrieve]
• Chan LY, Leung JC, Tang SC, Choy CB, Lai KN Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol 2005;16(8):2306-17.[Abstract/Free Full Text]
• Alexander RW Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995;25: 155-61.[Abstract/Free Full Text]
• Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-20.[Abstract]
• Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA. 1996;93:9114-19.http://hyper. ahajournals.org/cgi/ijlink?linkType=ABST&journalCode=p nas&resid=93/17/9114[Abstract/Free Full Text]
• Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;33:1066-71.
• Ushio-Fukai M., Alexander RW, Akers M., Griendling KK p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 1998;273:15022-9.[Abstract/Free Full Text]
• Luft FC, Mervaala E., Muller DN et al. Hypertension-induced end-organ damage: A new transgenic approach to an old problem. Hypertension 1999;33(1 Pt 2):212-18.[Abstract/Free Full Text]
• Nishiyama A., Seth DM, Navar LG Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 2002;39:129-34.[Abstract/Free Full Text]
• Parving HH, Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., Arner P. Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345(12): 870-8.[Abstract/Free Full Text]
• Rossing K., Schjoedt KJ, Jensen BR, Boomsma F., Parving HH Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 2005;68(3):119D0-8.
• Russo D., Minutolo R., Pisani A. et al. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 2001;38(1): 18-25.[Web of Science][Medline] [Order article via Infotrieve]
• Azizi M., Webb R., Nussberger I.J.,Hollenberg NK Renin inhibition with aliskiren: where are we now, and where are we going? J Hypertens 2006;24(2):243-56.[Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 2, 122-125 (2006)
DOI: 10.3317/jraas.2006.009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Haller, H. Articles by Menne, J. Search for Related Content PubMed PubMed Citation Articles by Haller, H. Articles by Menne, J. Social Bookmarking                         What's this?